8月23日辉瑞和BioNTech宣布了一项II/III期试验的更新疗效结果,公布了II/III期试验的更新疗效结果,该试验评估了辉瑞-BioNTech COVID-19疫苗在6个月至4岁儿童中的三个3µg剂量系列,加强了先前报告的3月收集的中期疫苗疗效数据。 该实验对三...
The Moderna COVID-19 vaccine has been granted Emergency Use Authorization (EUA) for children aged 6 months through 11 years. It is not an FDA-approved vaccine. Under the EUA, there is an option to accept or refuse to receive this vaccine. Should you decide for your child not to receive...
very frail older persons with an anticipated life expectancy of less than 3 months should be indiv...
6 months-39.46% Current year-35.72% More quotes Course Extremes 1 week 63.37 67.96 1 month 63.37 79.96 Current year 63.37 170.47 1 year 62.55 170.47 3 years 62.55 376.65 5 years 13.53 497.49 10 years 11.54 497.49 More quotes Other Biotechnology & Medical Research ...
Mar 23, 2022Moderna Announces its COVID-19 Vaccine Phase 2/3 Study in Children 6 Months to Under 6 Years Has Successfully Met Its Primary Endpoint Mar 17, 2022Moderna Submits Amendment to the Emergency Use Authorization for an Additional Booster Dose of its COVID-19 Vaccine in the U.S. ...
In KEYNOTE-051, 161 pediatric patients (62 pediatric patients aged 6 months to younger than 12 years and 99 pediatric patients aged 12 years to 17 years) were administered KEYTRUDA 2 mg/kg every 3 weeks. The median duration of exposure ...
The US Centers for Disease Control and Prevention and the Food and Drug Administration have approved both the Pfizer-BioNTech and Moderna covid-19 vaccines for children aged 6 months to 5 years.1 This is the final group eligible for vaccination in the US. CDC director Rochelle Walensky gave ...
Three Months Ended December 31, Years Ended December 31, 2023 2022 2023 2022 Revenue: Net product sales $ 2,793 $ 4,859 $ 6,671 $ 18,435 Other revenue1 18 225 177 828 Total revenue 2,811 5,084 6,848 19,263 Operating expenses: Cost o...
Moderna, Inc. today announced that it has submitted a request for emergency use authorization (EUA) for its COVID-19 vaccine (mRNA-1273) in children 6 months to under 2 years and 2 years to under 6 years of age to the U.S. Food and Dr...
Previously, the Moderna vaccine was already recommended for use in children 6 months through 5 years old and adults 18 years and older. "Today, we have expanded the options available to families by recommending a second safe and effective vaccine for children ages 6 through 17 years," said CD...